CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483 | -25.2% | 41,320 | -14.1% | 0.02% | -20.0% |
| Q2 2023 | $646 | -23.6% | 48,075 | -5.7% | 0.02% | -28.6% |
| Q1 2023 | $845 | -11.2% | 50,981 | -0.3% | 0.04% | -16.7% |
| Q4 2022 | $952 | -99.9% | 51,158 | -17.2% | 0.04% | +35.5% |
| Q3 2022 | $793,000 | +45.0% | 61,821 | -20.8% | 0.03% | +93.8% |
| Q2 2022 | $547,000 | -15.3% | 78,019 | +0.2% | 0.02% | +6.7% |
| Q1 2022 | $646,000 | +6.8% | 77,886 | -12.9% | 0.02% | +25.0% |
| Q4 2021 | $605,000 | +28.2% | 89,407 | +0.5% | 0.01% | +9.1% |
| Q3 2021 | $472,000 | -11.6% | 88,990 | -4.1% | 0.01% | +10.0% |
| Q2 2021 | $534,000 | +109.4% | 92,810 | +67.5% | 0.01% | +100.0% |
| Q1 2021 | $255,000 | – | 55,399 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |